MML Investors Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Buy |
3,495
+351
| +11% | +$39.9K | ﹤0.01% | 2239 |
|
|
2025
Q1 | $331K | Buy |
3,144
+680
| +28% | +$71.6K | ﹤0.01% | 2253 |
|
|
2024
Q4 | $264K | Buy |
2,464
+370
| +18% | +$39.6K | ﹤0.01% | 2339 |
|
|
2024
Q3 | $210K | Buy |
+2,094
| New | +$210K | ﹤0.01% | 2417 |
|
|
2019
Q4 | – | Sell |
-3,527
| Closed | -$219K | – | 1531 |
|
|
2019
Q3 | $219K | Buy |
+3,527
| New | +$219K | ﹤0.01% | 1359 |
|
|
2019
Q2 | – | Sell |
-2,868
| Closed | -$225K | – | 1632 |
|
|
2019
Q1 | $225K | Hold |
2,868
| – | – | ﹤0.01% | 1422 |
|
|
2018
Q4 | $243K | Buy |
2,868
+678
| +31% | +$57.4K | ﹤0.01% | 1273 |
|
|
2018
Q3 | $375K | Buy |
2,190
+324
| +17% | +$55.5K | 0.01% | 1163 |
|
|
2018
Q2 | $241K | Sell |
1,866
-1,082
| -37% | -$140K | 0.01% | 1182 |
|
|
2018
Q1 | $304K | Buy |
+2,948
| New | +$304K | 0.01% | 1062 |
|